Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 994 | 921 | 1003 | 1455 | - | - |
Fund Return | -0.62% | -7.85% | 0.34% | 13.32% | - | - |
Place in category | 181 | 86 | 179 | 83 | - | - |
% in Category | 44 | 15 | 42 | 22 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1058974137 | 4.44B | -0.40 | 12.41 | - | ||
LU1058973592 | 4.44B | 0.12 | 13.11 | - | ||
LU2145463027 | 3.16B | -8.74 | 3.62 | 8.74 | ||
LU2146191130 | 2.99B | -3.58 | 2.01 | 6.03 | ||
LU1079558364 | 472.87M | -0.75 | 4.94 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Robeco BP US Premium Equities I $ | 5.04B | 4.06 | 10.16 | 9.34 | ||
Robeco BP US Premium Equities K $ | 5.04B | 4.06 | 10.16 | 9.34 | ||
Robeco BP US Premium Equities F $ | 5.04B | 5.41 | 5.72 | 9.02 | ||
LU0226953718 | 5.04B | -1.43 | 12.22 | 7.39 | ||
JPMorgan US Value X Acc USD | 3.18B | 10.57 | 10.80 | 9.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
J&J | US4781601046 | 2.55 | 145.95 | +0.28% | |
Bristol-Myers Squibb | US1101221083 | 2.24 | 40.97 | -0.56% | |
Alphabet A | US02079K3059 | 2.04 | 177.24 | +0.25% | |
AbbVie | US00287Y1091 | 1.91 | 169.68 | +0.65% | |
Sanofi ADR | US80105N1054 | 1.83 | 47.29 | +2.25% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Strong Buy |
Technical Indicators | Strong Sell | Neutral | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review